The antiproliferative effect of the naturally occurring polyphenol chlorogenic acid (CGA) was evaluated in combination with either cisplatin or oxaliplatin in human cervical carcinoma cell lines that were either sensitive (A431) or resistant to cisplatin (A431Pt), in order to provide evidence to overcome drug resistance. Cytotoxicity of platinating drugs (IC 50 ~ 10 -6 -10 -5 M) was enhanced by 1-2 orders of magnitude by increasing incubation times (1, 4, and 24 hours) in the two cell lines. CGA treatment presented low cytotoxicity per se (IC 50 ~ 10 -4 M at 24 h) if compared with platinum drugs and its activity was similar in A431Pt cells and in their sensitive A431 counterpart. The combination of the platinating drugs with CGA (10 -6 -10 -4 M) indicated variable effects on cytotoxicity, ranging from potentiation to various degrees of antagonism (in A431 cells) and no effect (in A431Pt cells). In order to explain the different cytotoxic activity elicited by oxaliplatin and cisplatin in association with CGA, the possible presence of chemical interactions was investigated by HPLC analysis. The drug association with CGA caused evident changes in their chromatographic profile, suggesting occurrence of in vitro chemical interactions.
Conventional therapies such as chemotherapy and radiotherapy are the gold standard in cancer treatment. Unfortunately, tumor cells can become resistant to these therapies [1] [2] [3] . Polyphenols, plantderived compounds, are beneficial to human health and present antiinflammatory, anticancer, and immunomodulatory activities [4] [5] [6] [7] [8] . It has been reported that polyphenols modulate the pathways involved in carcinogenesis [9, 10] through either direct interaction or modulation of gene expression [6, 11] . Several in vitro and in vivo studies have shown that treatment with polyphenols in combination is more effective in inhibiting cancer growth than treatment with a single antitumor drug [9, 12, 13] . Combining polyphenols with conventional therapies may help to overcome drug resistance and reduce the side effects of standard anticancer treatments.
Chlorogenic acid (CGA), one of the most abundant polyphenolic compounds in the human diet, is an ester in which the acidic part of caffeic acid is bound to the hydroxyl group at position 5 of quinic acid (5-O-caffeoylquinic acid). CGA belongs to a group of phenolic compounds produced by some plant species and is an important metabolite of coffee, the amount of which ranges from 70 to 350 mg in a 200 mL cup of coffee [14] . Epidemiological studies have reported that CGA shows many biological properties, including antioxidant, anti-inflammatory, antiviral, and anticancer activities, and may be responsible for the reduced risk of some chronic diseases [15] [16] [17] [18] [19] .
In this study, using human cervical carcinoma cell lines either sensitive (A431) or resistant to cisplatin (A431Pt), the antiproliferative effect of GCA in combination with either cisplatin or oxaliplatin was evaluated, in order to provide evidence to overcome drug resistance and therefore reduce the dose of chemotherapeutic drugs. Figure 1 presents the response to cisplatin and oxaliplatin (10 -8 -10 -3 M) at different incubation times (1, 4, and 24 hours) in the two cell lines. Cytotoxicity was enhanced by 1-2 orders of magnitude by increasing incubation times, and drug resistance was confirmed with both platinum drugs. Table 1 reports the calculated IC 50 at different incubation times. CGA treatment for 24 h showed lower cytotoxicity per se (IC 50~ 10 -4 M) if compared with platinum drugs ( Figure 2 and Table 1) ; the activity was similar in A431Pt cells and in their sensitive A431 counterpart. The response to a combination treatment of platinating drugs with CGA (10 -6 -10 -4 M) was evaluated.
Cytotoxic effects:
The results obtained indicate that the presence of CGA (10 -6 -10 -4 M) caused a change in the activity of platinating drugs after 24 hours of treatment ( Figure 3 ). In particular, in the A431 cell line, at higher concentrations the co-treatment with CGA increased cisplatin activity; conversely, CGA 10 -6 M decreased cisplatin cytotoxicity with respect to cisplatin alone. Regarding oxaliplatin, at the lower concentration of CGA, the activity of the platinating drug was potentiated. On the contrary, CGA at 10 -5 M concentration decreased oxaliplatin activity with respect to the drug alone.
In the resistant A431Pt cell line, CGA did not modify the effect of cisplatin, except for the 10 -6 M concentration, which decreased cisplatin activity with respect to the drug alone. CGA at 10 -4 M concentration partially decreased oxaliplatin activity with respect to the drug alone. HPLC analysis: In order to explain the different cytotoxic activity elicited by oxaliplatin and cisplatin in the presence of CGA, the possible occurrence of chemical interactions was investigated by HPLC analysis. Figure 4 shows the chromatograms of either the single drugs or their association with CGA, all dissolved in phosphate-buffered saline (PBS). Cisplatin and oxaliplatin presented peaks at 2.85 and 3.65 min respectively. CGA presented three peaks, each corresponding to a different protonation state of the molecule in PBS solution. Considering the platinating drug association with CGA, their chromatographic profile showed evident changes. The peaks of cisplatin and oxaliplatin disappeared, while the association with oxaliplatin showed only one main peak, and in the case of the association with cisplatin, several peaks appeared, suggesting complex chemical interactions occurring.
Polyphenols possess anti-oxidant and anti-inflammatory properties and also modulate cell signaling pathways with anti-proliferative effects [4] [5] [6] [7] . However, the use of these compounds as anti-cancer agents is not as effective and hence combinations of chemotherapeutic drugs with these molecules have been attempted. Various studies report that in vitro and in vivo combinations of polyphenols and chemotherapeutic agents open up new perspectives in the identification of promising combinations for cancer therapy [9, 12, 13] .
The present investigation was aimed at the continuation of the search for new molecules for a rational and useful combination with platinating drugs. In a previous study, we identified curcumin as a naturally occurring substance able to enhance the activity of platinating drugs [20] . The efficacy of the combination of curcumin with cisplatin and oxaliplatin was demonstrated as a consequence of apoptosis induction and cell cycle modulation [20] . In order to determine if other natural products can synergistically enhance the activity of platinating drugs, cancer cell lines were co-treated with different polyphenols and either cisplatin or oxaliplatin [10] . Unexpectedly, CGA was found to have different effects on cisplatin and oxaliplatin-induced reduction of cell viability. In this study, we focused more specifically on the direct chemical interaction and the resulting antagonism between platin-based drugs and a naturally occurring abundant polyphenol. The HPLC profiles suggested that CGA binds cisplatin and oxaliplatin differently to form compounds either more active or inactive on cancer cells. This is demonstrated by the change in the oxaliplatin retention time from 3.65 min to 8.83 min when in association with CGA. Considering the respective chemical structures, the explanation can be that CGA sequesters oxaliplatin, so making the latter not available as a platinum drug.
For cisplatin the situation is more complex, because the cisplatin alone has a retention time of 2.85, but, in the chromatogram of its association with CGA, numerous peaks were observed. The data obtained with CGA suggest other points of view.
A study by Kim et al. [21] demonstrated for the first time with a systematic structural and mechanistic study the presence of direct chemical interactions of bortezomib with polyphenols. More importantly, their results may provide guidelines to bortezomib treatment and access to polyphenols from daily diets. In fact, Kim et al. [21] highlighted potential antagonistic effects induced by drugdrug interactions with bortezomib, suggesting that intake of natural polyphenols should be avoided during therapy with the drug, similarly to what is suggested for vitamin K-containing foods for patients treated with warfarin [21, 22] .
Our study shows further potential interactions between polyphenols and anticancer drugs. This aspect must be considered a significant aspect for efficacy and toxicity of anticancer therapy. However, although the present findings are still preliminary, they contain potentially relevant information that may suggest more detailed studies. 
Experimental
Cells: The A431 cell line was derived from human cervix squamous carcinoma; its CDDP-resistant variant (A431Pt) was selected by exposure to increasing CDDP concentrations for a period of 9 months [9, 10] . The cells were routinely grown in humidified conditions of 5% CO 2 at 37°C, incubated with RPMI 1640 medium, 10% FBS, 2% glutamine and 1% pen-strep. All reagents were from Cambrex-Lonza (Basel, Switzerland).
MTT assay:
Cell viability was determined using the 3-(4,5dimethyl-thizol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay, as previously described [9, 20] . Cells were plated in 96-well μL plates at a density of 2500/well. Following overnight incubation, cells were exposed to the test compounds; after 24 h, cells were added to 20 μL of MTT (5 mg/mL) (Sigma, St. Louis, MO, USA) and incubated for 4 h at 37°C. Formazan crystals produced by the conversion of MTT were solubilized by adding 200 μL of acidified isopropanol. The absorbance at 570 nm was determined using a VICTOR TMx3 Multilabel Reader (Perkin Elmer, Wellesley, MA, USA). HPLC analysis: Samples were prepared in PBS solution at a final concentration of 10 -3 M. Analytical conditions: HPLC-UV/VIS, using ChromQuest (Thermoseparation, San Jose, CA, USA), equipped with a P4000 pump and a UV6000 PDA detector. The column was a Nova-Pak RP-18 -4 μm (Waters, Milan, Italy) 150 x 3.9 mm provided with a guard column (20 x 2 mm I.D.).The mobile phase consisted of 0.01% H 3 PO 4 , CH 3 CN and CH 3 OH according to the gradient shown in Table 2 . The flow rate was kept at 1 mL/min and the injection volume was 20 µL. Chromatograms were acquired at wavelengths of 300 and 255 nm.
